Search - tctmd.com

Displaying 21 - 40 of 63

Sort: Relevancy | Date

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

News Industry News

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

February 13, 2017

News Industry News

Mercator MedSystems Announces First Patients Enrolled In U.S. Below The Knee (BTK) Clinical Trial In North Carolina And Texas

July 27, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Industry News

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

June 28, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

News Industry News

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

May 19, 2016

News Industry News

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

April 26, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Industry News

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

January 06, 2016

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

Advertisement

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

SELUTION™ First-in-Man Study Achieves Primary Endpoint

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

Mercator MedSystems Announces First Patients Enrolled In U.S. Below The Knee (BTK) Clinical Trial In North Carolina And Texas

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content